Eli Lilly Leverages Obesity Drug Profits for Acquisitions While GE Vernova Slides on Musk Comments

Eli Lilly plans to use windfall revenues from its blockbuster obesity treatments to fund further mergers and acquisitions, while shares of GE Vernova dropped following remarks made by Elon Musk.

31 Aug, 18:27 — 31 Aug, 18:27

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual12h ago

Lilly taps obesity windfall for more M&A. Plus, Elon Musk remarks pull GE Vernova lower

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.

Read full article →

Eli Lilly Leverages Obesity Drug Profits for Acquisitions While GE Vernova Slides on Musk Comments

Sources

Lilly taps obesity windfall for more M&A. Plus, Elon Musk remarks pull GE Vernova lower

Related Stories

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue

Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases

England Pharmacies to Offer Free Quick Cholesterol Screening Tests